In contrast, no such increases are seen in K-Ras wildtype cells after the same treatment, confirming that S7333 treatment in HCT-116 is not an off-target effect on K-Ras gene and that K-RasG13D mutation plays a role in increasing cancer cell proliferation and suppressing cancer stemness in colon cancer. Here, KRAS is linked to cancer.